Back to news
AnalysisJune 24, 2026· 3 min read

80% of Medicare denials get overturned on appeal — but almost no one appeals

More than 80% of prior authorization denials are overturned when appealed in Medicare Advantage, yet only a small fraction of beneficiaries ever file. What payers are missing upstream.

Our Take

The problem is not how appeals are processed—it's that the cases that should be appealed never reach the system in the first place, which means your visibility into decision failures is worse than you think.

Why it matters

Health plans are operating blind to systemic decision errors. As CMS increases oversight and members grow aware of their appeal rights, rising volumes will collide with workflow breakdowns that have nothing to do with staff effort or intelligence—only fragmented systems and manual tracking.

Do this week

Operations lead: map your end-to-end appeals workflow across teams and systems this week so you can identify where cases stall and where visibility breaks.

The gap between overturned denials and actual appeals

In Medicare Advantage, more than 80% of prior authorization denials are ultimately overturned when appealed (per the article, citing recent data). Yet only a small percentage of beneficiaries ever pursue an appeal in the first place. CMS and OIG findings show roughly 1% of denials are appealed at the first level despite those high overturn rates.

This is not a compliance technicality. When eight in ten denied cases can be reversed but fewer than one in a hundred are ever challenged, the system is not working as designed. The disconnect suggests appeals are not being accessed, understood, or trusted by the members and providers who should be using them.

Workflow failures compound faster than appeals volumes rise

Most payers treat appeals as a downstream process: measure turnaround times, manage compliance clocks, track documentation, and escalate when needed. This focus misses the actual problem. If the right cases are not entering the system, improving processing speed alone does nothing.

The real operational risk emerges from three sources. First, many organizations lack end-to-end visibility across multiple teams and systems, forcing reliance on manual tracking and individual follow-ups. Second, appeal volumes are rising as members and providers become more aware of their rights, creating tension between growing demand and flat or shrinking staff capacity. Third, fragmented systems make it impossible to maintain a consistent view of where cases sit, which directly degrades both speed and decision quality.

When workflow breaks down, teams stop managing a process and start chasing work. Delays and variability compound. The organization loses the ability to prioritize effectively because it lacks visibility into what matters most.

The consequence is not buried in operations data. It shows up in how members and providers experience the plan. Delays in care, confusion around status, and long resolution times shape perception directly. In serious cases where delays have clinical implications, reputational damage accelerates quickly.

Start by mapping where cases fail to surface

Appeals and grievances are one of the most visible moments in the member journey. When something goes wrong, it appears front and center for the member, provider, and everyone involved. This makes the appeals process a clear test of how your organization operates under pressure.

The operational takeaway is straightforward: if large shares of denials can be overturned but only small percentages are appealed, the problem is not in how you handle appeals once they arrive. The problem is earlier. Focus first on why the right cases are not entering the system. Improve workflow, visibility, and coordination. Reduce the manual burden on teams. Audit how decisions are communicated, how cases are understood, and how easy it is for providers to move a case forward.

Organizations that look only at what happens after an appeal is filed risk missing the larger issue entirely. Appeals reflect how well your plan functions under pressure and how effectively you surface, prioritize, and resolve the cases that matter most. As expectations rise and CMS scrutiny increases, that visibility becomes competitive advantage.

#Healthcare AI#Enterprise AI
Share:
Keep reading

Related stories